
PhenoTips
Most user-friendly and EMR-integrated software solution for medical genetics.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
CAD2.5m | Seed | ||
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 100 % | 4 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
PhenoTips operates in the healthcare technology sector, providing an integrated electronic health record (EHR) solution specifically designed for cancer genetics. The company serves healthcare providers, including clinicians and researchers, by offering tools that streamline the process of cancer risk assessment and diagnosis. PhenoTips' platform allows for the collection and analysis of genetic and phenotypic data, enabling more accurate and faster diagnosis. The business model is likely subscription-based, where clients pay for access to the software and its features. Revenue is generated through these subscriptions, as well as potential add-ons or premium features. The market it operates in includes hospitals, genetic counseling centers, and research institutions. By integrating multiple risk models and enabling collaboration on patient data, PhenoTips maximizes clinical resources and improves patient care. The platform also empowers patients to contribute to their own health records through digital questionnaires, enhancing the accuracy of family history data.
Keywords: EHR, cancer genetics, risk assessment, phenotyping, healthcare technology, genetic data, clinical resources, patient care, digital questionnaires, diagnosis.